Natco Pharma is an Indian pharmaceutical company with global operations, headquartered in Hyderabad. The company is engaged in the development, manufacturing, and marketing of finished dosage formulations (FDF), active pharmaceutical ingredients (APIs), and agrochemical products. Natco Pharma has a strong focus on niche therapeutic areas and complex products, particularly in oncology, cardiology, and diabetology. They are known for their research and development capabilities, which enable them to produce difficult-to-develop molecules and limited-competition generics for regulated markets like the United States and Europe. The company also has a significant presence in the domestic Indian market, especially in the oncology segment, and is expanding its reach in other therapeutic areas. Natco Pharma operates manufacturing facilities in India that cater to both domestic and international markets, and they also undertake contract manufacturing for other pharmaceutical companies. Their business strategy involves a focus on complex generics, strong R&D investment, backward integration into API manufacturing, and establishing a market presence in both regulated and emerging markets. Natco Pharma also has a crop health sciences division, manufacturing agrochemical products.